Skip to main content
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.02
-0.44 (-2.67%)
At close: Feb 27, 2026, 4:00 PM EST
16.03
+0.01 (0.06%)
After-hours: Feb 27, 2026, 7:42 PM EST

Adaptive Biotechnologies Revenue

In the year 2025, Adaptive Biotechnologies had annual revenue of $276.98M with 54.77% growth. Adaptive Biotechnologies had revenue of $71.68M in the quarter ending December 31, 2025, with 51.04% growth.

Revenue (ttm)
$276.98M
Revenue Growth
+54.77%
P/S Ratio
8.91
Revenue / Employee
$447,457
Employees
619
Market Cap
2.47B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025276.98M98.02M54.77%
Dec 31, 2024178.96M8.68M5.10%
Dec 31, 2023170.28M-15.03M-8.11%
Dec 31, 2022185.31M30.96M20.06%
Dec 31, 2021154.34M55.96M56.88%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Apellis Pharmaceuticals 1.00B
Travere Therapeutics 490.73M
Arcus Biosciences 247.00M
Wave Life Sciences 109.23M
Liquidia 69.22M
Ascentage Pharma Group International 54.52M
Immunome 9.68M
Maze Therapeutics 2.50M
Revenue Rankings

ADPT News

More News